A large federal study designed to settle the debate over whether hormone replacement therapy benefits postmenopausal women has been stopped.
Researchers say the risks associated with hormone replacement therapy, specifically using estrogen and progestin, outweigh the benefits.
The 16,000 women study was designed for eight years, but was halted after five. The Women's Health Initiative found that these hormones combined, raises a woman's risk for breast cancer, stroke, and heart disease.
Estrogen and progestin are commonly used to prevent osteoporosis and treat menopausal symptoms.
Doctors say it's hard to translate what this means for the average woman on the street because they say they don't know the risk factors associated with each woman.